p53 Mutation Is a Common Genetic Event in Ovarian Carcinoma

Cancer Research

Volumn 53, Issue 9, 1993, Pages 2128-2132

  Milner, Ben J ^a   Allan, Lindsey A ^a   Eccles, Diana M ^b   Kitchener, Henry C ^c   Leonard, Robert C F ^b   Kelly, Kevin F ^a   Parkin, David E ^c   Haites, Neva E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION;

BASE SEQUENCE; CARCINOMA; ELECTROPHORESIS, AGAR GEL; EXONS; FEMALE; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; OLIGODEOXYRIBONUCLEOTIDES; OVARIAN NEOPLASMS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0027230693     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lane, D. P. p. 3, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
2. Caron de Fromentel, C. and Soussi, T. Tp. 3 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4: 1-15, 1992.
3. Hollstein, M. Sidransky, D. Vogelstein, B. and Harris, C. C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
4. Baker, S. J. Fearon, E. R. Nigro, J. M. Hamilton, S. R. Preisinger, A. C. Jessup, J. M. van Tuinen, P. Ledbetter, D. H. Barker, D. F. Nakamura, Y. White, R. and Vogelstein, B. Chromosome 17 deletions and p. 3 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
5. Prosser, J. Thompson, A. M. Cranston, G. and Evans H. J. Evidence that p. 3 behaves as a tumor suppressor gene in sporadic breast tumors. Oncogene, 5: 1573-1579.
6. Takahashi. T. Nau, M. M. Chiba, I. Birrer, M. J. Rosenberg, R. K. Vinocour, M. Levitt, M. Pass, H. Gazdar, A. F. and Minna, J. D. p. 3: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
7. Mulligan, L. M. Matlashewski, G. J. Scrable, H. J. and Cavenee. W. K. Mechanisms of p. 3 loss in human sarcomas. Proc. Natl. Acad. Sci. USA, 87: 5863-5867, 1990.
8. Stratton, M. R. Moss, S. Warren, W. Patterson, H. Clark, J. Fisher, S. Fletcher, C. D. M. Ball, A. Thomas, M. Gusterson, B. A. and Cooper, C. S. Mutation of thep. 5 gene in human soft tissue sarcomas: association with abnormalities of the RBI gene. Oncogene. 5: 1297-1301, 1990.
9. Marks, J. R. Davidoff, A. M. Kerns, B. J. Humphrey, P. A. Pence, J. C. Dodge, R. K. Clarke-Pearson, D. L. Iglehart, J. D. Bast, R. C. Jr. and Berchuck, A. Overex-pression and mutation of p. 3 in epithelial ovarian cancer. Cancer Res. 51: 2979-2984, 1991.
10. Mazars. R. Pujol, P. Maudelonde, T. Jeanteur, P. and Theillet, C. p. 3 mutations in ovarian cancer: a late event? Oncogene, 6: 1685-1690, 1991.
11. Okamoto, A. Sameshima, Y. Yokoyama, S. Terashima, Y. Sugimura, T. Terada, M. and Yokota, J. Frequent allelic losses and mutations of the p. 3 gene in human ovarian cancer. Cancer Res. 51: 5171-5176, 1991.
12. Kihana, T. Tsuda, H. Teshima, S. Okada, S. Matsuura, S. and Hirohashi, S. High incidence of p. 3 gene mutation in human ovarian cancer and its association with nuclear accumulation of p. 3 protein and tumor DNA aneuploidy. Jpn. J. Cancer Res. 83: 978-984. 1992.
13. Naito, M. Satake, M. Sakai. E. Hirano, Y. Tsuchida, N. Kanzaki, H. Ito, Y. and Mori, T. Detection of p. 3 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis. Jpn. J. Cancer Res. 83: 1030-1036, 1992.
14. Nigro. J. M. Baker. S. J. Preisinger. A. C. Jessup, J. M. Hostetter, R. Cleary, K. Bigner. S. H. Davidson. N. Baylin. S. Devilee, P. Glover, T. Collins. F. S. Weston, A. Modali, R. Harris, C. C. and Vogelstein, B. Mutations in the p. 3 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708. 1989.
15. Bressac, B. Kew, M. Wands, J. and Ozturk, M. Selective G to T mutations of p. 3 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431. 1991.
16. Hsu. I. C. Metcalf. R. A. Sun, T. Welsh. A. Wang, N. J. and Harris. C. C. Mutational hotspot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428. 1991.
17. Sambrook, J. Fritsch. E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 9.17-9.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
18. Spinardi. L. Mazars, R. and Theillet, C. Protocols for an improved detection of point mutations by SSCP. Nucleic Acids Res. 19: 4009, 1991.
19. Orita, M. Suzuki, Y. Sekiya, T. and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
20. Sambrook. J. Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Ed. 2, pp. 13.45-13.57. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
21. Carbone, D. Chiba, I. and Mitsudomi, T. Polymorphism at codon 213 within the p. 3 gene. Oncogene, 6: 1691-1692. 1991.
22. Mazars. G. R. Jeanteur, P. Lynch, H. T. Lenoir, G. and Theillet, C. Nucleotide sequence polymorphism in a hotspot mutation region of the p. 3 gene. Oncogene. 7: 781-782, 1992.
23. Michaud. J. Brody, L. C. Steel, G. Fontaine, G. Martin, L. S. Valle, D. and Mitchell, G. Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine 5-aminotransferase gene. Genomics. 13: 389-394, 1992.
24. Sommer, S. S. Cunningham, J. McGovem, R. M. Saitoh, S. Schroeder, J. Wold, L. E. and Kovach, J. S. Pattern of p. 3 gene mutations in breast cancers of women of the midwestem United States. J. Natl. Cancer Inst. 84: 1992.
25. Kikuchi-Yanoshita, R. Konishi, M. Ito, S. Seki, M. Tanaka, K. Maeda, Y. lino, H. Fukayama, M. Koike, M. Mori, T. Sakuraba, H. Fukunara, H. Iwama, T. and Miyaki, M. Genetic changes of both p. 3 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 52: 3965-3971, 1992.
26. Eisenstadt. E. Warren, A. J. Porter, J. Atkins, D. and Miller, J. H. Carcinogenesis epoxides of benzo(a)pyrene and cyclopenta(cdyrene induce base substitutions via specific transversions. Proc. Natl. Acad. Sci. USA, 79: 1945-1949, 1982.
27. Puisieux, A. Lim, S. Groopman, J. and Ozturk, M. Selective targeting of p. 3 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 57: 6185-6189, 1991.
28. Ozturk, M. et al. p. 3 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338: 1356-1359, 1991.
29. Suzuki, H. Takahashi, T. Kuroishi, T. Suyama, M. Ariyoshi, Y. Takahashi, T. and Ueda, R. p. 3 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 52: 734-736, 1992.
30. Fearon, E. R. and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
31. Eccles, D. M. Russell, S. E. H. Haites. N. E. Atkinson, R. Bell, D. W. Gruber, L. Hickey, I. Kelly, K. Kitchener, H. Leonard, R. Lessells, A. Lowry, S. Miller, I. Milner, B. and Steel, M. Early loss of heterozygosity on 17q in ovarian cancer. Oncogene, 7: 2069-2072, 1992.